...
首页> 外文期刊>Clinical and experimental ophthalmology >Long-term visual outcomes in patients with orbitotemporal neurofibromatosis
【24h】

Long-term visual outcomes in patients with orbitotemporal neurofibromatosis

机译:眶颞神经纤维瘤病患者的长期视觉结果

获取原文
获取原文并翻译 | 示例

摘要

Background: The study aimed to review the presentation and long-term visual outcomes of patients with orbitotemporal neurofibromatosis. Design: Retrospective case series. Participants: Patients with orbitotemporal neurofibromatosis presenting from 1981 to 2009. Methods: Demographic data, examination findings, causes of vision impairment and interventions performed were recorded for each patient from presentation through subsequent follow-up encounters. Visual impairment was defined as an ipsilateral Snellen acuity of <6/12. Main Outcome Measures: The proportion of patients with visual impairment or enucleation, the rate of new vision loss during follow up; and causes for vision loss or enucleation. Results: Thirty-seven patients (17 female) were included. Median presenting age was 15 years (range 2-45) with an average follow up of 7.4 years (range 0.5-20.3). Visual impairment occurred in 54% of patients at presentation. Causes were amblyopia (13 of 37), optic atrophy (4 of 37), previous enucleation/evisceration (2 of 37), and optic nerve glioma (1 of 37). At presentation, 76% of patients had ptosis, and 51% had strabismus. Thirty-one patients had surgery, with an average of two procedures per patient. At final follow up, 62% had visual impairment. The rate of visual decline was 2% per patient-years. Causes of visual decline were two patients with optic nerve atrophy, one with exposure keratitis and one whose cause was unknown. Five blind patients had enucleation. Conclusions: The first series of orbitotemporal neurofibromatosis to focus on visual outcomes was presented. Vision loss is common, with a high prevalence of amblyopia. Close monitoring from an early age is needed to prevent visual impairment.
机译:背景:该研究旨在回顾眼眶颞神经纤维瘤病患者的表现和长期视觉效果。设计:回顾案系列。参与者:1981年至2009年就诊的眶颞神经纤维瘤病患者。方法:对从就诊到随后随访的每位患者记录人口统计数据,检查结果,视力障碍的原因以及所采取的干预措施。视力障碍定义为同侧Snellen视力<6/12。主要观察指标:视力障碍或摘除眼球的患者比例,随访期间新视力丧失的比例;以及造成视力丧失或摘除的原因。结果:共纳入37例患者(17例女性)。平均出现年龄为15岁(2-45岁),平均随访7.4年(0.5-20.3岁)。呈现时视力障碍发生在54%的患者中。原因是弱视(37例中的13例),视神经萎缩(37例中的4例),先前的摘除/除除术(37例中的2例)和视神经胶质瘤(37例中的1例)。介绍时,有76%的患者患有下垂,而51%的患者患有斜视。 31名患者接受了手术,平均每位患者进行两次手术。在最后的随访中,有62%的患者有视力障碍。视力下降的比率为每患者年2%。视力下降的原因是两名视神经萎缩患者,一名患有暴露性角膜炎,另一名原因不明。五名盲人患者已摘除眼球。结论:提出了第一系列眼颞神经纤维瘤病,其重点是视觉结果。视力丧失是常见的,弱视患病率很高。需要从小就严密监视以防止视力障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号